Skip to main content
Clinical Trials/NCT06165562
NCT06165562UnknownNot Applicable

Pressure Supporting Ventilation and Electroencephalography-guided Extubation for Free of Unwanted compLications (PEACEFUL): a Randomised Controlled Trial

Gangnam Severance Hospital1 site in 1 country120 target enrollmentStarted: January 5, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
120
Locations
1
Primary Endpoint
Lowest SpO2 after emergence

Study Overview

Brief Summary

This study aims to assess whether pressure supporting ventilation and electroencephalogram (EEG)-guided emergence can reduce airway complications after thyroid surgery compared with conventional emergence. Patients will be randomly assigned to either pressure supporting ventilation and EEG-guided emergence group (intervention group) or conventional emergence group (control group). Co-primary outcomes are the incidence of emergence coughing and lowest percutaneous oxygen saturation (SpO2) after emergence. Secondary outcomes included severity of emergence cough, emergence time, blood pressure and heart rate during emergence, Richmond Agitation-Sedation Scale (RASS) immediately after extubation and upon post-anesthesia care unit (PACU) arrival, incidence of desaturation during PACU stay, hoarseness, sore throat during PACU stay, duration of PACU stay, surgeon satisfaction regarding emergence process, postoperative pain score, and patient satisfaction score regarding emergence process.

Detailed Description

Adult patients aged < 40 years scheduled to undergo thyroid surgery will be screened for eligibility. Patients will be randomly allocate to either the intervention group or control group.

  • In the intervention group, pressure support ventilation will be applied from the start of subcutaneous suture until extubation. At the end of surgery, sevoflurane will be discontinued, and the attending anesthesiologist will perform tracheal extubation after observing the 'zipper opening' pattern on the EEG spectrogram, indicating the patient's recovery of consciousness. For safety reason, extubation will also be guided by the following processed EEG indices thresholds:
  1. 95% spectral edge frequency (SEF) ≥ 23
  2. Patient state index (PSI) ≥ 64
  • In the control group, conventional full-awake extubation will be performed based on the routine practice of our institution. At the end of surgery, sevoflurane will be stopped, and the attending anesthesiologist will lead the emergence process, allowing the patient to breathe spontaneously and providing intermittent manual assistance if necessary. Extubation will be performed when the patient meets the following criteria: obeys commands such as eye-opening or hand-grip, tidal volume > 5 ml/kg, end-tidal carbon dioxide < 45 mmHg, spontaneous respiratory rate 10 to 20 breaths/min.

In both groups, the Oxygen Reserve Index (ORi) will be monitored. Blinded investigator will assess the incidence of emergence coughing and the lowest SpO2 after emergence.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Investigator, Outcomes Assessor)

Masking Description

Patients, medical staff responsible for measuring outcome variables, surgeons, and nurses in the recovery room and wards will be blinded. This blinding approach ensures that both medical staff and patients remain unaware of the assigned group throughout the study.

Eligibility Criteria

Ages
19 Years to 39 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patients aged under 40 years who are scheduled to undergo thyroid surgery.

Exclusion Criteria

  • •Patients scheduled for radical neck dissection
  • •Patients scheduled for lymph node biopsy
  • •Patients with an anticipated difficult airway
  • •Patients experiencing difficulty during intubation
  • •Patients with a fasting time not meeting institutional policy
  • •Patients with a body mass index (BMI) greater than 30 kg/m²
  • •Patients with sleep apnea
  • •Pregnant or breastfeeding women
  • •Patients unable to communicate

Arms & Interventions

Pressure Supporting Ventilation (PSV) and EEG-guided Emergence group

Experimental

Pressure support ventilation will be applied from the start of subcutaneous suture until extubation. At the end of surgery, sevoflurane will be discontinued, and the attending anesthesiologist will perform tracheal extubation after observing the 'zipper opening' pattern on the EEG spectrogram, indicating the patient's recovery of consciousness. For safety reason, extubation will also be guided by the following processed EEG indices thresholds:

  1. 95% spectral edge frequency (SEF) ≥ 23
  2. Patient state index (PSI) ≥ 64

Intervention: EEG-Guidance (Procedure)

Pressure Supporting Ventilation (PSV) and EEG-guided Emergence group

Experimental

Pressure support ventilation will be applied from the start of subcutaneous suture until extubation. At the end of surgery, sevoflurane will be discontinued, and the attending anesthesiologist will perform tracheal extubation after observing the 'zipper opening' pattern on the EEG spectrogram, indicating the patient's recovery of consciousness. For safety reason, extubation will also be guided by the following processed EEG indices thresholds:

  1. 95% spectral edge frequency (SEF) ≥ 23
  2. Patient state index (PSI) ≥ 64

Intervention: Spontaneous Respiration (Procedure)

Conventional Emergence group

Active Comparator

Conventional full-awake extubation will be performed based on the routine practice of our institution. At the end of surgery, sevoflurane will be stopped, and the attending anesthesiologist will lead the emergence process, allowing the patient to breathe spontaneously and providing intermittent manual assistance if necessary. Extubation will be performed when the patient meets the following criteria: obeys commands such as eye-opening or hand-grip, tidal volume > 5 ml/kg, end-tidal carbon dioxide < 45 mmHg, spontaneous respiratory rate 10 to 20 breaths/min.

Intervention: Intermittent Manual Assistance (Procedure)

Conventional Emergence group

Active Comparator

Conventional full-awake extubation will be performed based on the routine practice of our institution. At the end of surgery, sevoflurane will be stopped, and the attending anesthesiologist will lead the emergence process, allowing the patient to breathe spontaneously and providing intermittent manual assistance if necessary. Extubation will be performed when the patient meets the following criteria: obeys commands such as eye-opening or hand-grip, tidal volume > 5 ml/kg, end-tidal carbon dioxide < 45 mmHg, spontaneous respiratory rate 10 to 20 breaths/min.

Intervention: Obey Command (Procedure)

Conventional Emergence group

Active Comparator

Conventional full-awake extubation will be performed based on the routine practice of our institution. At the end of surgery, sevoflurane will be stopped, and the attending anesthesiologist will lead the emergence process, allowing the patient to breathe spontaneously and providing intermittent manual assistance if necessary. Extubation will be performed when the patient meets the following criteria: obeys commands such as eye-opening or hand-grip, tidal volume > 5 ml/kg, end-tidal carbon dioxide < 45 mmHg, spontaneous respiratory rate 10 to 20 breaths/min.

Intervention: Spontaneous Respiration (Procedure)

Pressure Supporting Ventilation (PSV) and EEG-guided Emergence group

Experimental

Pressure support ventilation will be applied from the start of subcutaneous suture until extubation. At the end of surgery, sevoflurane will be discontinued, and the attending anesthesiologist will perform tracheal extubation after observing the 'zipper opening' pattern on the EEG spectrogram, indicating the patient's recovery of consciousness. For safety reason, extubation will also be guided by the following processed EEG indices thresholds:

  1. 95% spectral edge frequency (SEF) ≥ 23
  2. Patient state index (PSI) ≥ 64

Intervention: PSV (Procedure)

Outcomes

Primary Outcomes

Lowest SpO2 after emergence

Time Frame: During the time period from sevoflurane cessation until post-anesthesia care unit (PACU) discharge, an average of 1 hour

Lowest SpO2 after emergence (defined as the lowest SpO2 value during the time period from sevoflurane off to post-anesthesia care unit (PACU) discharge)

Incidence of emergence coughing

Time Frame: During the time period from sevoflurane cessation until 5 minutes after extubation

Incidence of emergence coughing (defined as coughing during the time period from sevoflurane off until 5 minutes after extubation)

Secondary Outcomes

  • Incidence and severity of sore throat(During the time period from PACU admission until PACU discharge, an average of 40 minutes)
  • Incidence and severity of coughing during PACU stay(During the time period from PACU admission until PACU discharge, an average of 40 minutes)
  • Time to leave operating room(During the time period from sevoflurane cessation until leaving operating room, an average of 30 minutes)
  • Emergence time(During the time period from sevoflurane cessation until tracheal extubation, an average of 20 minutes)
  • Severity of Emergence coughing(During the time period from sevoflurane cessation until 5 minutes after extubation.)
  • Richmond Agitation-Sedation Scale (RASS) immediately after extubation and upon PACU arrival(RASS will be assessed at two time points; (1) immediately after tracheal extubation, and (2) immediately after PACU arrival)
  • Blood pressure during emergence(during the time period from sevoflurane off until 5 minutes after extubation)
  • Heart rate during emergence(during the time period from sevoflurane off until 5 minutes after extubation)
  • Incidence of endotracheal tube biting(During the time period from sevoflurane cessation until tracheal extubation, an average of 20 minutes)
  • Hypoventilation after extubation (RR <8/min)(During the time period from PACU admission until PACU discharge, an average of 40 minutes)
  • Duration of PACU stay(During the time period from PACU admission until PACU discharge, an average of 40 minutes)
  • Surgeon satisfaction regarding emergence process encompassing smoothness/safety/speed(Immediately after the transfer of the patient from operating room to PACU)
  • Pain score during PACU stay(During the time period from PACU admission until PACU discharge, an average of 40 minutes)
  • Patient satisfaction score regarding emergence process(During the time period from PACU admission until PACU discharge, an average of 40 minutes)
  • Incidence of desaturation during PACU stay(During the time period from PACU admission until PACU discharge, an average of 40 minutes)
  • Hoarseness(During the time period from PACU admission until PACU discharge, an average of 40 minutes)
  • Incidence of awareness with recall(During the time period from PACU admission until PACU discharge, an average of 40 minutes)
  • reoperation(After operation, through the hospitalization, an average of 3 days.)
  • Incidence of Postoperative hematoma(After operation, through the hospitalization, an average of 3 days.)
  • Incidence of wound dehiscence(After operation, through the hospitalization, an average of 3 days.)
  • Oxygen Reserve Index(During the period from sevoflurane cessation until PACU discharge, an average of 1 hour)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Young Song

Associcate Professor

Gangnam Severance Hospital

Study Sites (1)

Loading locations...

Similar Trials